I’m the managing partner for PrescriptionDrugs.com, a premium healthcare domain with real SEO and business upside.
I’m looking for a US-based builder/operator to own the product and tech while I handle revenue, partnerships, compliance posture, and go-to-market. This is an equity partnership, not a freelance gig.
The concept (not locked):
A modern drug-data API that keeps medication info fresh, easy to read, and easy to plug into.
Nightly FDA label updates/diffs (with citations)
Clean NDC ↔ RxCUI mappings
Short, plain-English explainers for patient-facing use
Likely 3–4 core endpoints to start, but we’ll finalize with pilot prospects
How we’ll work (simple path):
MVP0 (no heavy dev): quick site refresh on PrescriptionDrugs.com to explain the vision and collect pilot interest.
Pilot discovery: we meet prospects together, confirm pain points, pick the top 2–3 must-haves.
MVP1 (you build): lean API + basic console that solves those jobs.
Iterate: improve with real feedback; adjust roadmap and timeline together.
Structure & comp: Equity. We’ll choose a fair setup together:
Value the domain up front and share upside on value created; or
Form a newco that leases/options the domain with performance milestones.
(Open to the approach that best aligns incentives.)
Why this is real:
The primary domain owner previously partnered with a software engineer in 2016; ~10 years later that company achieved a nine-figure exit.
I’ve exited a software company and currently work at another that’s in an active exit. My background: product, support, operations, sales. I’ll run the RevOps side so you can focus on building.
You:
US-based (Florida is a plus, not required)
Full-stack, can ship MVPs quickly (LLM/AI experience helpful)
Product-minded and comfortable owning technical direction
Entrepreneurial; equity-first is fine; want to co-design with pilot customers
If this fits, send:
2–3 links (GitHub/portfolio/LinkedIn)
A couple sentences on APIs or LLM features you’ve shipped
Your US location and weekly availability
Let’s co-design the plan with real users and build something valuable—together.
Really like what you’re building with PrescriptionDrugs.com it’s a strong, high-upside idea if implemented right.
We can help you get the MVP (site + API + console) live for $8,000 fully fixed cost no hidden charges, and you’ll have complete ownership of everything. I’m from Zaaric, We’re based in Pakistan, which keeps costs lean, but many US and EU healthcare startups already operate this way with remote teams here including those working under FDA and HIPAA-aligned processes.
Once the MVP is up, you can always bring in a US-based CTO for equity with something real to show. We can help you reach that stage quickly and cleanly.
If that makes sense, I’d love to walk you through how we’d structure the build super lean, milestone-based, and built to move fast.
You’re right. This is a high-stakes asset, and I’ve seen how tough it is to find the right partner without losing momentum.
But your passive approach to the equity partnership is costing you pure leverage. Asking the builder to co-design the compensation and plan leaves the domain’s scarcity on the table.
Pivot now: issue a Non-Negotiable Term Sheet with a clear $1M revenue target and demand a partner who can map out exactly how they’ll hit it.
That’s the leak, plain and simple. How are you locking in a builder who delivers?
Hi Phil, I have a dev team that can help. I'd like to hear the pitch over a call. Not sure how to message you, is there an email?
I like that you're focused on a real potential problem, and figuring out how to create product/market fit. Once we discover that, we can scale it up, and the TAM is big.
I'm well connected in silicon valley as well if we need to fund raise later.
Interesting concept, Phil. Instead of searching for a single co-founder, you might consider collaborating with a specialized Data/AI company that can handle the technical development end-to-end. This could help you accelerate the MVP build, integrate LLM/AI capabilities faster, and free you to focus more on partnerships and go-to-market execution.